Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Need an interpretation....Ro...

There has been some debate recently (during your absense) about the meaning and intent of resolution (ii) in the following (extract from latest PR):

"On April 20, 2010 the Management Committee of PDS passed resolutions specifying that (i) any and all future licenses of the MMP Patent Portfolio must be approved in writing by a majority of the members of the Management Committee before they are agreed to or signed by TPL and (ii) effective immediately, TPL must not market patent portfolios in which PDS does not have an interest with the MMP Patent Portfolio. The TPL representative on the PDS Management Committee voted against the resolutions, and TPL has not expressed its acquiescence to the resolutions."

Your input will be appreciated.

TIA,

SGE

1
pjw
May 03, 2010 02:58PM
Share
New Message
Please login to post a reply